Fundraising Fox
Oleg Nodelman
InvestorFounder + Portfolio Manager at EcoR1 Capital
San Francisco, California, United States
Find your path to Oleg
Sign up to see every warm intro you have to Oleg
- Paths you didn't know you had: your email and LinkedIn already hold routes to Oleg. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Founder and Portfolio Manager of EcoR1 Capital with over twenty years of biotech investing experience; previously a portfolio manager at BVF Partners and currently a board member of several publicly traded biotech companies. Holds a BS in Foreign Service from Georgetown University.
Contact· self-published, not guessed
Invests in
Biotech
Deals · 2
Aktis OncologyBoard seat
via EcoR1 Capital · filed Oct 2024 · $175M raise
Scorpion TherapeuticsBoard seat
via EcoR1 Capital · filed Jul 2024 · $150M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
AnaptysBioEpikastLakefront BiotherapeuticsReCode TherapeuticsZymeworks
Sources: SEC Form D filings · the firm's website.
Colleagues at EcoR1 Capital
Frequently asked questions
- Who is Oleg Nodelman?
- Founder and Portfolio Manager of EcoR1 Capital with over twenty years of biotech investing experience; previously a portfolio manager at BVF Partners and currently a board member of several publicly traded biotech companies. Holds a BS in Foreign Service from Georgetown University.
- Where does Oleg Nodelman work?
- Oleg Nodelman is Founder + Portfolio Manager at EcoR1 Capital.
- What does Oleg Nodelman invest in?
- Oleg Nodelman invests in Biotech.
- What boards does Oleg Nodelman sit on?
- Oleg Nodelman holds tracked board seats at Aktis Oncology, AnaptysBio, Epikast, Lakefront Biotherapeutics, ReCode Therapeutics, Scorpion Therapeutics, Zymeworks.
About this profile. Compiled from public sources — EcoR1 Capital's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights